These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2451306

  • 61. Studies on components of the contact phase system in patients with advanced gastrointestinal cancer.
    Roeise O, Sivertsen S, Ruud TE, Bouma BN, Stadaas JO, Aasen AO.
    Cancer; 1990 Mar 15; 65(6):1355-9. PubMed ID: 1689607
    [Abstract] [Full Text] [Related]

  • 62. Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways.
    Salmon J, Cardigan R, Mackie I, Cohen SL, Machin S, Singer M.
    Intensive Care Med; 1997 Jan 15; 23(1):38-43. PubMed ID: 9037638
    [Abstract] [Full Text] [Related]

  • 63. Prekallikrein, HMW-kininogen and factor XII in various disease states.
    Deutsch E, Dragosics B, Kopsa H, Mannhalter C, Rainer H.
    Thromb Res; 1983 Jul 15; 31(2):351-64. PubMed ID: 6356459
    [Abstract] [Full Text] [Related]

  • 64. Peritoneal lavage efficiently eliminates protease-alpha-2-macroglobulin complexes and components of the contact system from the peritoneal cavity in patients with severe acute pancreatitis.
    Aasen AO, Ruud TE, Roeise O, Bouma BN, Stadaas JO.
    Eur Surg Res; 1989 Jul 15; 21(1):1-10. PubMed ID: 2469582
    [Abstract] [Full Text] [Related]

  • 65. The biochemistry and pathophysiology of the contact system of plasma.
    Cochrane CG, Griffin JH.
    Adv Immunol; 1982 Jul 15; 33():241-306. PubMed ID: 6182767
    [No Abstract] [Full Text] [Related]

  • 66. Prekallikrein activation, C1 esterase inhibitor, and factor XII as predictors of adverse reaction to contrast media. A prospective study.
    Hagan JJ, Yost FJ, Nickoloff EL.
    Invest Radiol; 1987 Jun 15; 22(6):490-4. PubMed ID: 3497903
    [Abstract] [Full Text] [Related]

  • 67. Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway.
    Clemens R, Pramoolsinsap C, Lorenz R, Pukrittayakamee S, Bock HL, White NJ.
    Br J Haematol; 1994 May 15; 87(1):100-5. PubMed ID: 7947233
    [Abstract] [Full Text] [Related]

  • 68. Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome.
    Pixley RA, Zellis S, Bankes P, DeLa Cadena RA, Page JD, Scott CF, Kappelmayer J, Wyshock EG, Kelly JJ, Colman RW.
    Crit Care Med; 1995 Jan 15; 23(1):41-51. PubMed ID: 7528118
    [Abstract] [Full Text] [Related]

  • 69. C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation.
    Nürnberger W, Heying R, Burdach S, Göbel U.
    Ann Hematol; 1997 Sep 15; 75(3):95-101. PubMed ID: 9368478
    [Abstract] [Full Text] [Related]

  • 70. Kinin activation as a predictive assay for adverse reactions to radiographic contrast medium.
    Carr DH, Walker AC.
    Acta Radiol Diagn (Stockh); 1984 Sep 15; 25(4):337-42. PubMed ID: 6567445
    [Abstract] [Full Text] [Related]

  • 71. Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis.
    Nuijens JH, Huijbregts CC, Eerenberg-Belmer AJ, Abbink JJ, Strack van Schijndel RJ, Felt-Bersma RJ, Thijs LG, Hack CE.
    Blood; 1988 Dec 15; 72(6):1841-8. PubMed ID: 3264190
    [Abstract] [Full Text] [Related]

  • 72. Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.
    de Agostini A, Lijnen HR, Pixley RA, Colman RW, Schapira M.
    J Clin Invest; 1984 Jun 15; 73(6):1542-9. PubMed ID: 6725552
    [Abstract] [Full Text] [Related]

  • 73. A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies.
    Vinazzer H, Woler M.
    Haemostasis; 1986 Jun 15; 16(2):106-15. PubMed ID: 2423420
    [Abstract] [Full Text] [Related]

  • 74. Complexes of Cl-inhibitor (Cl-INH) and hemostatic enzymes in normal plasma.
    Donaldson VH, Harrison RR.
    Adv Exp Med Biol; 1983 Jun 15; 156():149-55. PubMed ID: 6602461
    [No Abstract] [Full Text] [Related]

  • 75. Plasma inhibitor of glomerular fibrinolysis in the hemolytic-uremic syndrome.
    Bergstein JM, Kuederli U, Bang NU.
    Am J Med; 1982 Sep 15; 73(3):322-7. PubMed ID: 6181678
    [Abstract] [Full Text] [Related]

  • 76. [Prekallikrein deficiency: apropos of 2 cases].
    Joggi J, Stalder M, Knecht H, Hauert J, Bachmann F.
    Schweiz Med Wochenschr; 1990 Dec 15; 120(50):1942-4. PubMed ID: 2270450
    [Abstract] [Full Text] [Related]

  • 77. Computerized immunoblot analyses (CIBA) of the distribution of prekallikrein and its activation products in vivo and in vitro.
    Veloso D, Campbell G.
    Agents Actions Suppl; 1992 Dec 15; 38 ( Pt 1)():166-73. PubMed ID: 1281607
    [Abstract] [Full Text] [Related]

  • 78. Mononuclear cell chemotactic activity of kallikrein and plasminogen activator and its inhibition by C1 inhibitor and alpha 2-macroglobulin.
    Gallin JI, Kaplan AP.
    J Immunol; 1974 Dec 15; 113(6):1928-34. PubMed ID: 4214866
    [No Abstract] [Full Text] [Related]

  • 79. A model for the interplay of inflammatory mediators in sepsis--a study in 48 patients.
    Hack CE, Nuijens JH, Strack van Schijndel RJ, Abbink JJ, Eerenberg AJ, Thijs LG.
    Intensive Care Med; 1990 Dec 15; 16 Suppl 3():S187-91. PubMed ID: 2289988
    [Abstract] [Full Text] [Related]

  • 80. Contact phase of blood coagulation in cardiogenic pulmonary oedema (CPO) and adult respiratory distress syndrome (ARDS).
    Herrera C, Velasco F, Guerrero A, Guerrero R, Alvarez F, Torres A.
    Intensive Care Med; 1989 Dec 15; 15(2):99-104. PubMed ID: 2715514
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.